Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
Dreyling, Martin, Prof Dr, Jurczak, Wojciech, MD, Jerkeman, Mats, MD, Silva, Rodrigo Santucci, MD, Rusconi, Chiara, MD, Trneny, Marek, Prof, Offner, Fritz, MD, Caballero, Dolores, MD, Joao, Cristina, Prof, Witzens-Harig, Mathias, Prof, Hess, Georg, MD, Bence-Bruckler, Isabelle, MD, Cho, Seok-Goo, Prof, Bothos, John, PhD, Goldberg, Jenna D, MD, Enny, Christopher, BS, Traina, Shana, PhD, Balasubramanian, Sriram, PhD, Bandyopadhyay, Nibedita, PhD, Sun, Steven, PhD, Vermeulen, Jessica, MD, Rizo, Aleksandra, MD, Rule, Simon, Prof
Published in The Lancet (British edition) (20.02.2016)
Published in The Lancet (British edition) (20.02.2016)
Get full text
Journal Article
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study
Younes, Anas, Prof, Thieblemont, Catherine, Prof, Morschhauser, Franck, Prof, Flinn, Ian, MD, Friedberg, Jonathan W, Prof, Amorim, Sandy, MD, Hivert, Benedicte, MD, Westin, Jason, MD, Vermeulen, Jessica, MD, Bandyopadhyay, Nibedita, PhD, de Vries, Ronald, MSc, Balasubramanian, Sriram, PhD, Hellemans, Peter, MD, Smit, Johan W, PhD, Fourneau, Nele, Oki, Yasuhiro, MD
Published in The lancet oncology (01.08.2014)
Published in The lancet oncology (01.08.2014)
Get full text
Journal Article
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers
Felip, Enriqueta, Moreno, Victor, Morgensztern, Daniel, Curigliano, Giuseppe, Rutkowski, Piotr, Trigo, José Manuel, Calvo, Aitana, Kowalski, Dariusz, Cortinovis, Diego, Plummer, Ruth, Maio, Michele, Ascierto, Paolo A., Vladimirov, Vladimir I., Cervantes, Andres, Zudaire, Enrique, Hazra, Anasuya, T’jollyn, Huybrecht, Bandyopadhyay, Nibedita, Greger, James G., Attiyeh, Edward, Xie, Hong, Calvo, Emiliano
Published in Cancer chemotherapy and pharmacology (01.04.2022)
Published in Cancer chemotherapy and pharmacology (01.04.2022)
Get full text
Journal Article
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies
Brahmer, Julie R., Johnson, Melissa L., Cobo, Manuel, Viteri, Santiago, Sarto, Juan Coves, Sukari, Ammar, Awad, Mark M., Salgia, Ravi, Papadimitrakopoulou, Vali A., Rajan, Arun, Bandyopadhyay, Nibedita, Allred, Alicia J., Wade, Mark, Mason, Gary E., Zudaire, Enrique, Knoblauch, Roland E., Stone, Nicole, Lorenzi, Matthew V., Hassan, Raffit
Published in JTO clinical and research reports (01.02.2021)
Published in JTO clinical and research reports (01.02.2021)
Get full text
Journal Article
Non-standard asymptotics in an inhomogeneous gamma process
Bandyopadhyay, Nibedita, Sen, Ananda
Published in Annals of the Institute of Statistical Mathematics (01.12.2005)
Published in Annals of the Institute of Statistical Mathematics (01.12.2005)
Get full text
Journal Article
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
Chi, Kim N, Chowdhury, Simon, Bjartell, Anders, Chung, Byung Ha, Pereira de Santana Gomes, Andrea J, Given, Robert, Juárez, Alvaro, Merseburger, Axel S, Özgüroğlu, Mustafa, Uemura, Hirotsugu, Ye, Dingwei, Brookman-May, Sabine, Mundle, Suneel D, McCarthy, Sharon A, Larsen, Julie S, Sun, Weili, Bevans, Katherine B, Zhang, Ke, Bandyopadhyay, Nibedita, Agarwal, Neeraj
Published in Journal of clinical oncology (10.07.2021)
Published in Journal of clinical oncology (10.07.2021)
Get full text
Journal Article
Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation
Wang, Judy, Martin-Romano, Patricia, Cassier, Philippe, Johnson, Melissa, Haura, Eric, Lenox, Laurie, Guo, Yue, Bandyopadhyay, Nibedita, Russell, Michael, Shearin, Elizabeth, Lauring, Josh, Dahan, Laetitia
Published in The oncologist (Dayton, Ohio) (05.07.2022)
Published in The oncologist (Dayton, Ohio) (05.07.2022)
Get full text
Journal Article
Safety and preliminary clinical activity of JNJ-63898081 (JNJ-081), a PSMA and CD3 bispecific antibody, for the treatment of metastatic castrate-resistant prostate cancer (mCRPC)
Lim, Emerson A., Schweizer, Michael Thomas, Chi, Kim N., Aggarwal, Rahul Raj, Agarwal, Neeraj, Gulley, James L., Attiyeh, Edward F., Greger, James, Wu, Shujian, Jaiprasart, Pharavee, Loffredo, John, Bandyopadhyay, Nibedita, Xie, Hong, Hansen, Aaron Richard
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Lim, Emerson A., Schweizer, Michael T., Chi, Kim N., Aggarwal, Rahul, Agarwal, Neeraj, Gulley, James, Attiyeh, Edward, Greger, James, Wu, Shujian, Jaiprasart, Pharavee, Loffredo, John, Bandyopadhyay, Nibedita, Xie, Hong, Hansen, Aaron R.
Published in Clinical genitourinary cancer (01.06.2023)
Published in Clinical genitourinary cancer (01.06.2023)
Get full text
Journal Article
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
Bhatla, Teena, Hogan, Laura E., Teachey, David T., Bautista, Francisco, Moppett, John, Velasco Puyó, Pablo, Micalizzi, Concetta, Rossig, Claudia, Shukla, Neerav, Gilad, Gil, Locatelli, Franco, Baruchel, André, Zwaan, C. Michel, Bezler, Natalie S., Rubio-San-Simón, Alba, Taussig, David C., Raetz, Elizabeth A., Mao, Zhengwei J., Wood, Brent L., Alvarez Arias, Diana, Krevvata, Maria, Nnane, Ivo, Bandyopadhyay, Nibedita, Lopez Solano, Lorena, Dennis, Robyn M., Carson, Robin, Vora, Ajay
Published in Blood (16.08.2024)
Published in Blood (16.08.2024)
Get full text
Journal Article
Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study
Hogan, Laura E., Bhatla, Teena, Teachey, David T., Sirvent, Francisco José Bautista, Moppett, John, Puyó, Pablo Velasco, Micalizzi, Concetta, R?Ssig, Claudia, Shukla, Neerav, Gilad, Gil, Locatelli, Franco, Baruchel, Andre, Zwaan, C. Michel, Raetz, Elizabeth A., Bandyopadhyay, Nibedita, Lopez Solano, Lorena, Dennis, Robyn Monet, Carson, Robin L., Vora, Ajay
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT)
Chi, Kim N., Chowdhury, Simon, Bjartell, Anders, Chung, Byung Ha, Pereira de Santana Gomes, Andrea Juliana, Given, Robert, Juárez Soto, Álvaro, Merseburger, Axel Stuart, Ozguroglu, Mustafa, Uemura, Hirotsugu, Ye, Dingwei, Triantos, Spyros, Mundle, Suneel, McCarthy, Sharon Anne, Larsen, Julie S., Sun, Weili, Bevans, Katherine, Zhang, Ke, Bandyopadhyay, Nibedita, Agarwal, Neeraj
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer
Drake, Charles G., Pachynski, Russell K., Subudhi, Sumit K., McNeel, Douglas G., Antonarakis, Emmanuel S., Bauer, Todd M., Lauer, Peter, Brockstedt, Dirk, Patricia, Daniel, Wade, Mark, Zudaire, Enrique, Bandyopadhyay, Nibedita, Parasrampuria, Dolly A., Girgis, Suzette, Mason, Gary E., Knoblauch, Roland E., Stone, Nicole, Infante, Jeffrey R., Gottardis, Marco M., Fong, Lawrence
Published in Prostate cancer and prostatic diseases (01.02.2022)
Published in Prostate cancer and prostatic diseases (01.02.2022)
Get full text
Journal Article
Subcutaneous Daratumumab with Rapid Corticosteroid Tapering in Relapsed or Refractory Multiple Myeloma Patients: Part 3 Update of the Open-Label, Multicenter, Phase 1b Pavo Study
Nahi, Hareth, Usmani, Saad Z., Mateos, Maria-Victoria, van de Donk, Niels W.C.J., Moreau, Philippe, Oriol, Albert, Plesner, Torben, Bandyopadhyay, Nibedita, Hellemans, Peter, Tromp, Brenda, Nnane, Ivo, Zemlickis, Donna, Farnsworth, Andrew, Chari, Ajai
Published in BLOOD (2021)
Published in BLOOD (2021)
Get full text
Journal Article
Conference Proceeding
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study
Nahi, Hareth, Usmani, Saad Z., Mateos, Maria-Victoria, van de Donk, Niels W. C. J., Oriol, Albert, Plesner, Torben, Bandyopadhyay, Nibedita, Hellemans, Peter, Tromp, Brenda, Nnane, Ivo, Zemlickis, Donna, Chari, Ajai, Moreau, Philippe
Published in Leukemia & lymphoma (28.01.2023)
Published in Leukemia & lymphoma (28.01.2023)
Get full text
Journal Article
Lymphoma Symptoms: Data from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL) Treated with Ibrutinib Vs. Temsirolimus
Hess, Georg, Rule, Simon, Jurczak, Wojciech, Jerkeman, Mats, Santucci, Rodrigo, Rusconi, Chiara, Caballero, Dolores, Joao, Cristina M., Witzens-Harig, Mathias, Bence-Bruckler, Isabelle, Cho, Seok-Goo, Bandyopadhyay, Nibedita, Goldberg, Jenna, Bothos, John, Enny, Christopher, Vermeulen, Jessica, Traina, Shana, Dreyling, Martin H.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article